IPSC vs GILD: Which Stock is Better?
Side-by-side comparison of Century Therapeutics Inc and Gilead Sciences Inc in 2026
IPSC
Century Therapeutics Inc
$2.59
GILD
Gilead Sciences Inc
$138.55
Key Metrics Comparison
| Metric | IPSC | GILD | Winner |
|---|---|---|---|
| Market Cap | $425.94M | $173.48B | GILD |
| P/E Ratio | N/A | 20.61 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | 12.4% | 78.8% | GILD |
Analyze IPSC
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPSC or GILD a better investment?
Comparing IPSC and GILD: Century Therapeutics Inc has a market cap of $425.94M while Gilead Sciences Inc has $173.48B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPSC and GILD?
IPSC (Century Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPSC or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPSC or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for IPSC.
Which company is more profitable: IPSC or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 12.4% for IPSC.
Which is the larger company: IPSC or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $173.48B compared to $425.94M for IPSC.
Should I buy IPSC or GILD in 2026?
Both IPSC and GILD have investment merit. IPSC trades at $2.59 while GILD trades at $138.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPSC and GILD stock?
Key differences: Market Cap ($425.94M vs $173.48B), P/E Ratio (N/A vs 20.6x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (12.4% vs 78.8%).